Paul H Edelstein

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nature microbiology

Antimicrobial agents and chemotherapy

Perelman School of Medicine University of Pennsylvania

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Perelman School of Medicine University of Pennsylvania

United States

Professor :: Pathology and Laboratory Medicine

Publications

Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology (2024)
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology 9 (5) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology 9 (5) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, Prema Shanmugasundaram, Anilkumar Jain, Marasamy Bathragiri, Manoranjan Pattnaik, Jyotirmayee Turuk, Ramesh Karunaianantham, Senthilkumar Balakrishnan, Sangamitra Pati, A K Hemanth Kumar, Manoj Kumar Rathore, Jegadeesh Raja, K Raghu Naidu, John Horn, Laura J Whitworth, Roger F Sewell, Lalita Ramakrishnan, Soumya Swaminathan, Paul H Edelstein
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis. Clinical pharmacology and therapeutics (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Marcel A Behr, Eva Kaufmann, Jacalyn Duffin, Paul H Edelstein, Lalita Ramakrishnan
Latent Tuberculosis: Two Centuries of Confusion. American journal of respiratory and critical care medicine 204 (2) (2021)
Laura J Whitworth, Jacob Coxon, Arjan van Laarhoven, Nguyen Thuy Thuong Thuong, Sofiati Dian, Bachti Alisjahbana, Ahmad Rizal Ganiem, Reinout van Crevel, Guy E Thwaites, Mark Troll, Paul H Edelstein, Roger F Sewell, Lalita Ramakrishnan
A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis. eLife 10 (2021)
Laura J Whitworth, Rajan Troll, Antonio J Pagán, Francisco J Roca, Paul H Edelstein, Mark Troll, David M Tobin, Nguyen Hoan Phu, Nguyen Duc Bang, Guy E Thwaites, Nguyen Thuy Thuong Thuong, Roger F Sewell, Lalita Ramakrishnan
Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. Proceedings of the National Academy of Sciences of the United States of America 118 (10) (2021)
Paul H Edelstein, Romney M Humphries
Improbable Results of Urine Isolate Antimicrobial Susceptibility Testing. Antimicrobial agents and chemotherapy 65 (1) (2020)
Paul H Edelstein, Charlotte Sværke Jørgensen, Leslie A Wolf
Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis. PloS one 15 (8) (2020)
Paul H Edelstein
Azithromycin Phenotypic versus Clinical Resistance. Antimicrobial agents and chemotherapy 64 (1) (2019)

Paul H Edelstein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul H Edelstein